Marty Makary

accelerated
Favicon Fierce Biotech

Regeneron, Sanofi receive 1- to 2-month priority review vouchers

The national priority vouchers position companies including Merck KGaA, Regeneron and Sanofi to complete the review process in one to two months.
Nick Paul Taylor Oct 17, 2025 8:30am
Marty Makary FDA Commissioner

Marty Makary deems DTC drug advertising 'a public health crisis'

Sep 15, 2025 11:00am
FDA

Under Trump, FDA seeks to abandon expert reviews of new drugs

Sep 12, 2025 9:50am
Trump Donald Trump

Trump, RFK Jr. lay out plan to rein in DTC drug advertising

Sep 10, 2025 11:28am
FDA
Favicon Fierce Biotech

FDA plans real-time release of drug rejection letters

Sep 4, 2025 1:45pm
FDA

Vinay Prasad is back at the FDA after last month's surprise ouster

Aug 9, 2025 12:22pm